Citations (4)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Krithika Rajagopalan, Nazia Rashid & Dilesh Doshi. (2023) Patients treated with pimavanserin or quetiapine for Parkinson’s disease psychosis: analysis of health resource utilization patterns among Medicare beneficiaries. Journal of Medical Economics 26:1, pages 769-776.
Read now
Read now
Articles from other publishers (3)
Krithika Rajagopalan, Nazia Rashid & Dilesh Doshi. (2024) Risk of long-term care admissions among Medicare beneficiaries treated with pimavanserin or quetiapine for Parkinson's disease psychosis in USA: a retrospective administrative claims database analysis. Journal of Comparative Effectiveness Research 13:1.
Crossref
Crossref
Krithika Rajagopalan, Nazia Rashid, Daksha Gopal & Dilesh Doshi. (2023) Incremental health care resource utilization and costs associated among patients with Parkinson's disease psychosis and incident dementia: An analysis of medicare beneficiaries. International Journal of Geriatric Psychiatry 38:11.
Crossref
Crossref
Capucine Piat, Aidan F. Mullan, Cole D. Stang, Mania Hajeb, Emanuele Camerucci, Pierpaolo Turcano, Peter R. Martin, James H. Bower & Rodolfo Savica. (2023) Risk of hospitalization in synucleinopathies and impact of psychosis. Frontiers in Aging Neuroscience 15.
Crossref
Crossref